Reuters Pharma USA 2024 – Serena Goodwin
AI is changing workflows for all kinds of pharma stakeholders, including sales representatives and medical affairs liaisons.
Newsletters and Deep Dive digital magazine
AI is changing workflows for all kinds of pharma stakeholders, including sales representatives and medical affairs liaisons.
Cell and gene therapies were a major topic of discussion this year at Reuters Pharma USA in Philadelphia.
Most of the exciting work being done right now in cancer immunotherapy is centred on highly targeted approaches that aim to activate only the most necessary immune responses to eliminate a
In today's era of cell, gene, and tissue therapies, new treatments are truly game-changing, often creating an opportunity for a healthy, normal life for people who previously had no options
One of the most salient topics in the United States right now in pharma is market access and drug affordability, and one thing that’s driving that topic in this moment are the drug pricing
Editor's Picks
Newsletters and Deep Dive
digital magazine